STAT3 and glioblastoma: Another analysis of 111 patients with glioblastoma showed that 76.6% of the specimens had a positive staining for phosphorylated STAT3-Tyr705 (pSTAT3Tyr705), and those patients carrying tumors with a strong staining had a shorter survival caused by a more aggressive subtype [42].